Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00851708
Other study ID # NAC vs DKT
Secondary ID FAPESP 06/52046-
Status Completed
Phase N/A
First received February 25, 2009
Last updated February 27, 2009

Study information

Verified date February 2009
Source University of Sao Paulo
Contact n/a
Is FDA regulated No
Health authority Brazil: Ministry of Health
Study type Interventional

Clinical Trial Summary

The aim of this interventional, prospective, randomized clinical trial is to evaluate the impact of the antioxidant N-acetylcysteine on oxidative stress in the first seven postoperative days and on renal function in the first three postoperative months in deceased kidney transplantation.


Recruitment information / eligibility

Status Completed
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- First transplant

- Deceased kidney transplant

Exclusion Criteria:

- postoperative recovery at critical care unit

- illicit drug addiction

- psychiatric disorders

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Drug:
N-acetylcysteine
600 mg bid orally from day 1 to 7 postoperative

Locations

Country Name City State
Brazil Clinics Hospital, University of Sao Paulo, Medical School São Paulo

Sponsors (2)

Lead Sponsor Collaborator
University of Sao Paulo Fundação de Amparo à Pesquisa do Estado de São Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Tiobarbituric acid reactive species measures First seven postoperative days No
Secondary Serum creatinine 7, 15, 30, 60, 90 postoperative day No